Novo Nordisk is increasing its drug development capacity by investing over 500 million Danish Kroner in a new research and development facility in Bagsværd, Denmark.
The purification plant will expand the company’s capacity to produce active pharmaceutical ingredients (APIs) for a growing number of diabetes drugs under development.
Project Management – Pharmaceutical research and development facility
Novo Nordisk has a wide portfolio of large and complex investment projects and is constantly seeking highly skilled project management resources.
The new pharmaceutical research and development facility is the largest investment project in Novo Nordisk R&D in decades and the team of project engineers and chemists throughout the project team counts several hundred people. More than 5 km of pipes will be installed and the process areas will be clean room class C. The new R&D facility will employ approx. 30 people and supply batches of new products ready for clinical testing.
emendo is responsible for the overall Project Management and reports to the client's Senior Management. The Project Management task consists of management of client resources and engineering partners in an EPCM contract as well as the classical Project Management disciplines: Risk Management, Project Controls, Stakeholder Management, Scope Management and Quality and Validation Management.
When using emendo a/s you get access to our knowledge network with the possibility to use specific project related resources in the short term. This makes the Project Management very efficient and agile. The knowledge network consist of 200+ years of Project Management experience in pharma.
emendo a/s is specialized in Project Management in the pharma business with bases in Copenhagen, Kalundborg and Raleigh, North Carolina, USA.
Managing complex projects and aiming higher
It takes experienced and skilled people to run complex pharma projects successfully.
It takes emendo Project Managers to make the clients aim higher and be successful in all aspects of the project lifecycle. The new R&D facility is ready in the spring of 2016 to the benefit of the world’s diabetics.